Evidence map›Paper›PMID 20600580›Full record

ArticleExperimental hematology2010

Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1.

Ping Xiang, Chaoyu Lo, Bob Argiropoulos, C Benjamin Lai, Arefeh Rouhi, Suzan Imren, Xiaoyan Jiang, Dixie Mager, R Keith Humphries

Open access · greenAbstract read
In one paragraph

Article in Experimental hematology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Predicting the molecular role of MEIS1 in esophageal squamous cell carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ping XiangTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Chaoyu Lo
Bob Argiropoulos
C Benjamin Lai
Arefeh Rouhi
Suzan Imren
Xiaoyan Jiang
Dixie Mager
R Keith Humphries
BC Cancer Agency · CAUniversity of British Columbia · CA

Funding

CIHR 92093-1
6 · The paper itself

Abstract

objectiveMyeloid ectropic viral integration site 1 (MEIS1) is a Hox cofactor known for its role in development and is strongly linked to normal and leukemic hematopoiesis. Although previous studies have focused on identifying protein partners of MEIS1 and its transcriptionally regulated targets, little is known about the upstream transcriptional regulators of this tightly regulated gene. Understanding the regulation of MEIS1 is important to understanding normal hematopoiesis and leukemogenesis. MATERIALS AND

methodsHere we describe our studies focusing on the evolutionary conserved putative MEIS1 promoter region. Phylogenetic sequence analysis and reporter assays in MEIS1-expressing (K562) and nonexpressing (HL60) leukemic cell line models were used to identify key regulatory regions and potential transcription factor binding sites within the candidate promoter region followed by functional and expression studies of one identified regulator in both cell lines and primary human cord blood and leukemia samples.

resultsChromatin status of MEIS1 promoter region is associated with MEIS1 expression. Truncation and mutation studies coupled with reporter assays revealed that a conserved ETS family member binding site located 289 bp upstream of the annotated human MEIS1 transcription start site is required for promoter activity. Of the three ETS family members tested, only ELF1 was enriched on the MEIS1 promoter as assessed by both electrophoretic mobility shift assay and chromatin immunoprecipitation experiments in K562. This finding was confirmed in MEIS1-expressing primary human samples. Moreover, small interfering RNA-mediated knockdown of ELF1 in K562 cells was associated with a decreased MEIS1 expression.

conclusionsWe conclude that the ETS transcription factor ELF1 is an important positive regulator of MEIS1 expression.

Indexed as

Gene Expression Regulation, LeukemicResponse ElementsFetal BloodGene Knockdown TechniquesHL-60 CellsHomeodomain ProteinsHumansK562 CellsLeukemiaMyeloid Ecotropic Viral Integration Site 1 ProteinNeoplasm ProteinsNuclear ProteinsTranscription FactorsELF1 protein, humanHomeodomain ProteinsMEIS1 protein, humanMyeloid Ecotropic Viral Integration Site 1 ProteinNeoplasm ProteinsNuclear ProteinsTranscription Factors

Identifiers

PMID20600580
PMCPMC3887005
OpenAlexW1984806209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.